PaxMedica, Inc. Common Stock
PXMD
PXMD was delisted on the 1st of May, 2024.
8 hedge funds and large institutions have $64.7K invested in PaxMedica, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
11% less funds holding
Funds holding: 9 → 8 (-1)
23% less capital invested
Capital invested by funds: $84.2K → $64.7K (-$19.4K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFA
Souders Financial Advisors
Cincinnati,
Ohio
|
+$23.5K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$15.3K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$3.14K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$162 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$16 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$21.2K |
| 2 |
VF
Virtu Financial
New York
|
-$11.3K |
| 3 |
JP Morgan Chase
New York
|
-$4.31K |
| 4 |
CA
Clearstead Advisors
Cleveland,
Ohio
|
-$1.32K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$372 |
PXMD Hedge Fund Activity: Q1 2024 in Review
8 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in PaxMedica, Inc. Common Stock (PXMD) for Q1 2024, worth a combined $64.7K — down 23% from $84.2K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PXMD and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 4 added.
The largest buyer was Souders Financial Advisors, opening a new position worth an estimated $23.5K. The largest seller was Citadel Advisors, exiting entirely with an estimated $21.2K sold.
- 8 institutional investors held PaxMedica, Inc. Common Stock (PXMD) as of Q1 2024, down from 9 in Q4 2023.
- Funds reported $64.7K of PaxMedica, Inc. Common Stock stock for Q1 2024, down 23% quarter-over-quarter.
- 2 funds opened new PaxMedica, Inc. Common Stock positions in Q1 2024 and 3 closed out, a net change of -1 holder.
- The largest PaxMedica, Inc. Common Stock buyer in Q1 2024 was Souders Financial Advisors, an estimated $23.5K added.
- The largest PaxMedica, Inc. Common Stock seller in Q1 2024 was Citadel Advisors, an estimated $21.2K sold.
Based on aggregated 13F filings for Q1 2024.